Global MPN Clinical Trials 101: Understanding MPN Research Around the World

MPN United Webinar Series – March 27, 2026

This session provides an introductory overview of the global MPN clinical trial landscape, including available treatments, the need for international research, and the challenges many countries face in running MPN studies. The webinar also highlights how trials are designed and conducted, and the important role patient advocates play in supporting research worldwide.

Key Learning Objectives:

• Understand the global MPN landscape
• Learn what treatments are available today
• Understand why global trials are needed
• Recognize why trials are hard to run in many countries
• Learn how MPN trials are designed and conducted
• Understand the role of global advocates

Speaker:
Dr. Abdulraheem Yacoub, Professor of Hematologic Malignancies and Cellular Therapeutics
Dr. Yacoub specializes in the diagnosis and treatment of complex blood cancers, with a focus on innovative and emerging therapies. He leads the clinical and research program of chronic myeloid malignancies and is internationally recognized in MPNs and MDS.

Best Practice Spotlight

Organization: HEMA‑ONKO
Presenter: Milica Kuzmanovska
Presentation: Driving Early Diagnosis and Systemic Change: The Impact of HEMA‑ONKO in Macedonia

Key Topics:

1. The role of patient organizations in advancing early diagnosis of hematological malignancies (MPNs)
2. Building effective collaboration between advocates, clinicians, and policymakers
3. Transforming patient advocacy into an equal partner in national healthcare decision-making
4. Government engagement – Cancer Plan 2025
5. Patient‑centered collaboration